BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA

Stagnation in clinical outcomes as well as severe side-effects of current treatment approaches for Group 3 medulloblastoma have prompted the search for novel therapies. To date, immunotherapies have not demonstrated success in medulloblastoma. Due to the highly aggressive nature of relapsed medullob...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Zahra, Hii, Hilary, Buck, Jessica, Johnson, Iley, Byrne, Jacob, Elaskalani, Omar, Kuchibhotla, Mani, George, Courtney, Arias, Clara Andradas, Howlett, Meegan, Lesterhuis, Joost, Johns, Terrance, Gottardo, Nicholas, Endersby, Raelene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Basic Biology/Stem Cells/Models - BIOL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260032/
http://dx.doi.org/10.1093/neuonc/noad073.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260032/
http://dx.doi.org/10.1093/neuonc/noad073.031

Ejemplares similares